These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22215838)

  • 1. Low incidence of catheter-related complications in patients with advanced pulmonary arterial hypertension undergoing continuous epoprostenol infusion.
    Nagai T; Kohsaka S; Anzai T; Yoshikawa T; Fukuda K; Sato T
    Chest; 2012 Jan; 141(1):272-273. PubMed ID: 22215838
    [No Abstract]   [Full Text] [Related]  

  • 2. [Transition from intravenous to subcutaneous prostacyclin in pulmonary hypertension].
    Escribano Subías P; Cea-Calvo L; Tello de Menesses R; Gómez Sánchez MA; Delgado Jiménez JF; Sáenz de la Calzada C
    Rev Esp Cardiol; 2003 Aug; 56(8):818-21. PubMed ID: 12892628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension.
    Rich JD; Glassner C; Wade M; Coslet S; Arneson C; Doran A; Gomberg-Maitland M
    Chest; 2012 Jan; 141(1):36-42. PubMed ID: 21659437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications associated with peripherally inserted central catheters and Hickman™ in patients with advanced pulmonary hypertension treated with intravenous prostanoids.
    Hinojosa W; Cruz A; Cruz-Utrilla A; Cristo Ropero MJ; López-Medrano F; Gómez I; Arribas-Ynsaurriaga F; Escribano-Subias P
    Respir Med; 2021; 189():106649. PubMed ID: 34673343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous catheter infections in pulmonary arterial hypertension.
    Gaine S; Gomberg-Maitland M
    Int J Clin Pract Suppl; 2008 Jul; (160):3-4. PubMed ID: 18638169
    [No Abstract]   [Full Text] [Related]  

  • 6. Subclinical venous access infection and clinical worsening in pulmonary arterial hypertension.
    Chebib N; Mornex JF; Cottin V
    J Heart Lung Transplant; 2017 Mar; 36(3):369-370. PubMed ID: 27914895
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tunnelled central venous line-associated infections in patients with pulmonary arterial hypertension treated with intravenous prostacyclin].
    Boucly A; O'Connell C; Savale L; O'Callaghan DS; Jaïs X; Montani D; Humbert M; Simonneau G; Sitbon O
    Presse Med; 2016 Jan; 45(1):20-8. PubMed ID: 26547673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closed-hub systems with protected connections and the reduction of risk of catheter-related bloodstream infection in pediatric patients receiving intravenous prostanoid therapy for pulmonary hypertension.
    Ivy DD; Calderbank M; Wagner BD; Dolan S; Nyquist AC; Wade M; Nickels WM; Doran AK
    Infect Control Hosp Epidemiol; 2009 Sep; 30(9):823-9. PubMed ID: 19637961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The "bouncing" catheter.
    Malaczynska-Rajpold K; Kurzyna M; Koteja A; Torbicki A; Mularek-Kubzdela T
    Cardiol J; 2016; 23(5):552-553. PubMed ID: 27723062
    [No Abstract]   [Full Text] [Related]  

  • 10. Treprostinil Administered to Treat Pulmonary Arterial Hypertension Using a Fully Implantable Programmable Intravascular Delivery System: Results of the DelIVery for PAH Trial.
    Bourge RC; Waxman AB; Gomberg-Maitland M; Shapiro SM; Tarver JH; Zwicke DL; Feldman JP; Chakinala MM; Frantz RP; Torres F; Cerkvenik J; Morris M; Thalin M; Peterson L; Rubin LJ
    Chest; 2016 Jul; 150(1):27-34. PubMed ID: 27396777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension.
    Oudiz RJ; Widlitz A; Beckmann XJ; Camanga D; Alfie J; Brundage BH; Barst RJ
    Chest; 2004 Jul; 126(1):90-4. PubMed ID: 15249447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term continuous intravenous infusion of prostacyclin for severe primary pulmonary hypertension.
    Okano Y; Senju S; Tsutsui Y; Kyotani S; Ishibashi M; Yoshida M; Kunieda T
    Intern Med; 1997 Nov; 36(11):794-8. PubMed ID: 9392352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flolan infusion interruption: a lethal complication during venous access.
    Falk A; Lookstein RA; Mitty HA
    J Vasc Interv Radiol; 2001 May; 12(5):667-8. PubMed ID: 11340154
    [No Abstract]   [Full Text] [Related]  

  • 14. Central venous blood oxygen saturation monitoring in patients with chronic pulmonary arterial hypertension treated with continuous IV epoprostenol: correlation with measurements of hemodynamics and plasma brain natriuretic peptide levels.
    Chin KM; Channick RN; Kim NH; Rubin LJ
    Chest; 2007 Sep; 132(3):786-92. PubMed ID: 17646224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous epoprostenol treatment of patients with connective tissue disease and pulmonary arterial hypertension at a single center.
    Shirai Y; Yasuoka H; Takeuchi T; Satoh T; Kuwana M
    Mod Rheumatol; 2013 Nov; 23(6):1211-20. PubMed ID: 23359006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Totally Implantable IV Treprostinil Therapy in Pulmonary Hypertension Assessment of the Implantation Procedure.
    Waxman AB; McElderry HT; Gomberg-Maitland M; Burke MC; Ross EL; Bersohn MM; Pangarkar SS; Tarver JH; Zwicke DL; Feldman JP; Chakinala MM; Frantz RP; Thompson GB; Torres F; Rauck RL; Clagg K; Durst L; Li P; Morris M; Southall KL; Peterson L; Bourge RC
    Chest; 2017 Dec; 152(6):1128-1134. PubMed ID: 28583617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1 across the lung circulation in patients with pulmonary arterial hypertension and influence of epoprostenol infusion.
    Selimovic N; Andersson B; Bergh CH; Sakiniene E; Carlsten H; Rundqvist B
    J Heart Lung Transplant; 2009 Aug; 28(8):808-14. PubMed ID: 19632577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of catheter-related infections using a closed hub system in patients with pulmonary arterial hypertension.
    Akagi S; Matsubara H; Ogawa A; Kawai Y; Hisamatsu K; Miyaji K; Munemasa M; Fujimoto Y; Kusano KF; Ohe T
    Circ J; 2007 Apr; 71(4):559-64. PubMed ID: 17384460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of continuous intravenous epoprostenol therapy on advanced primary pulmonary hypertension in Taiwanese patients.
    Hsu HH; Chen JS; Kuo SH; Chiang FT; Ko WJ; Kuo SW; Huang SC; Lee YC
    J Formos Med Assoc; 2005 Jan; 104(1):60-3. PubMed ID: 15660181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Continuous intravenous prostacyclin therapy].
    Miyaji K; Matsubara H
    Nihon Rinsho; 2008 Nov; 66(11):2139-44. PubMed ID: 19051733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.